Enhanced passive safety surveillance of Vaxigrip (trivalent inactivated split virion influenza vaccine, IM route) and Intanza 15 (trivalent inactivated split virion influenza vaccine, ID route) vaccines in Europe during the influenza season 2015/16

Trial Profile

Enhanced passive safety surveillance of Vaxigrip (trivalent inactivated split virion influenza vaccine, IM route) and Intanza 15 (trivalent inactivated split virion influenza vaccine, ID route) vaccines in Europe during the influenza season 2015/16

Completed
Phase of Trial: Phase IV

Latest Information Update: 19 Jul 2016

At a glance

  • Drugs Influenza virus vaccine (Primary) ; Influenza virus vaccine (Primary)
  • Indications Influenza virus infections
  • Focus Adverse reactions
  • Sponsors sanofi pasteur MSD
  • Most Recent Events

    • 13 Jul 2016 Status changed from active, no longer recruiting to completed.
    • 28 Jan 2016 According to United Kingdom Clinical Research Network record, status changed from recruiting to active, no longer recruiting.
    • 27 Nov 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top